• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MICU1 驱动卵巢癌中的糖酵解和化疗耐药性。

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

机构信息

Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.

Department of Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.

出版信息

Nat Commun. 2017 May 22;8:14634. doi: 10.1038/ncomms14634.

DOI:10.1038/ncomms14634
PMID:28530221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5477507/
Abstract

Cancer cells actively promote aerobic glycolysis to sustain their metabolic requirements through mechanisms not always clear. Here, we demonstrate that the gatekeeper of mitochondrial Ca uptake, Mitochondrial Calcium Uptake 1 (MICU1/CBARA1) drives aerobic glycolysis in ovarian cancer. We show that MICU1 is overexpressed in a panel of ovarian cancer cell lines and that MICU1 overexpression correlates with poor overall survival (OS). Silencing MICU1 in vitro increases oxygen consumption, decreases lactate production, inhibits clonal growth, migration and invasion of ovarian cancer cells, whereas silencing in vivo inhibits tumour growth, increases cisplatin efficacy and OS. Mechanistically, silencing MICU1 activates pyruvate dehydrogenase (PDH) by stimulating the PDPhosphatase-phosphoPDH-PDH axis. Forced-expression of MICU1 in normal cells phenocopies the metabolic aberrations of malignant cells. Consistent with the in vitro and in vivo findings we observe a significant correlation between MICU1 and pPDH (inactive form of PDH) expression with poor prognosis. Thus, MICU1 could serve as an important therapeutic target to normalize metabolic aberrations responsible for poor prognosis in ovarian cancer.

摘要

癌细胞通过机制主动促进有氧糖酵解,以维持其代谢需求,但这些机制并不总是清楚。在这里,我们证明了线粒体钙摄取的守门员,线粒体钙摄取 1 (MICU1/CBARA1),在卵巢癌中驱动有氧糖酵解。我们表明,MICU1 在一系列卵巢癌细胞系中过表达,并且 MICU1 的过表达与整体生存率(OS)差相关。体外沉默 MICU1 会增加耗氧量,减少乳酸生成,抑制卵巢癌细胞的克隆生长、迁移和侵袭,而体内沉默则会抑制肿瘤生长,增加顺铂的疗效和 OS。在机制上,沉默 MICU1 通过刺激 PDH 磷酸酶-磷酸化 PDH-PDH 轴来激活丙酮酸脱氢酶(PDH)。在正常细胞中强制表达 MICU1 可模拟恶性细胞的代谢异常。与体外和体内的研究结果一致,我们观察到 MICU1 与 pPDH(PDH 的无活性形式)表达之间存在显著相关性,与预后不良相关。因此,MICU1 可以作为一个重要的治疗靶点,纠正导致卵巢癌预后不良的代谢异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/4916a76c8620/ncomms14634-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/184e64addcae/ncomms14634-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/538b3a93f56d/ncomms14634-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/d7df5c0c440e/ncomms14634-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/b3f94e30f1ce/ncomms14634-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/c78614660f1f/ncomms14634-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/5e5751d663fe/ncomms14634-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/4916a76c8620/ncomms14634-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/184e64addcae/ncomms14634-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/538b3a93f56d/ncomms14634-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/d7df5c0c440e/ncomms14634-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/b3f94e30f1ce/ncomms14634-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/c78614660f1f/ncomms14634-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/5e5751d663fe/ncomms14634-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe9/5477507/4916a76c8620/ncomms14634-f7.jpg

相似文献

1
MICU1 drives glycolysis and chemoresistance in ovarian cancer.MICU1 驱动卵巢癌中的糖酵解和化疗耐药性。
Nat Commun. 2017 May 22;8:14634. doi: 10.1038/ncomms14634.
2
MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer.MicroRNA-195 调控卵巢癌细胞中 MICU1 的表达和肿瘤生长。
EMBO Rep. 2020 Oct 5;21(10):e48483. doi: 10.15252/embr.201948483. Epub 2020 Aug 27.
3
Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles.利用纳米颗粒探究线粒体单转运蛋白在卵巢癌细胞中的新作用。
J Biol Chem. 2013 Jun 14;288(24):17610-8. doi: 10.1074/jbc.M112.435206. Epub 2013 Apr 24.
4
MICU1 Serves as a Molecular Gatekeeper to Prevent In Vivo Mitochondrial Calcium Overload.MICU1作为分子守门人可防止体内线粒体钙超载。
Cell Rep. 2016 Aug 9;16(6):1561-1573. doi: 10.1016/j.celrep.2016.07.011. Epub 2016 Jul 28.
5
RPS3 regulates melanoma cell growth and apoptosis by targeting Cyto C/Ca2+/MICU1 dependent mitochondrial signaling.RPS3通过靶向细胞色素C/钙离子/线粒体钙摄取蛋白1依赖的线粒体信号传导来调节黑色素瘤细胞的生长和凋亡。
Oncotarget. 2015 Oct 6;6(30):29614-25. doi: 10.18632/oncotarget.4868.
6
Mitochondrial pyruvate and fatty acid flux modulate MICU1-dependent control of MCU activity.线粒体丙酮酸和脂肪酸通量调节 MCU 活性的 MICU1 依赖性控制。
Sci Signal. 2020 Apr 21;13(628):eaaz6206. doi: 10.1126/scisignal.aaz6206.
7
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca levels and tumor growth.Akt 介导的 MICU1 磷酸化调节线粒体 Ca 水平和肿瘤生长。
EMBO J. 2019 Jan 15;38(2). doi: 10.15252/embj.201899435. Epub 2018 Nov 30.
8
Mitochondrial Ca2+ uptake 1 (MICU1) and mitochondrial ca2+ uniporter (MCU) contribute to metabolism-secretion coupling in clonal pancreatic β-cells.线粒体钙摄取 1(MICU1)和线粒体钙单向转运蛋白(MCU)有助于克隆胰腺β细胞的代谢-分泌偶联。
J Biol Chem. 2012 Oct 5;287(41):34445-54. doi: 10.1074/jbc.M112.392084. Epub 2012 Aug 17.
9
MICU1 and MICU2 Play an Essential Role in Mitochondrial Ca Uptake, Growth, and Infectivity of the Human Pathogen Trypanosoma cruzi.MICU1 和 MICU2 在人病原体克氏锥虫的线粒体钙摄取、生长和感染性中发挥重要作用。
mBio. 2019 May 7;10(3):e00348-19. doi: 10.1128/mBio.00348-19.
10
MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca(2+) uptake that regulates cell survival.MICU1 是 MCU 介导的线粒体 Ca(2+)摄取的必要守门员,调节细胞存活。
Cell. 2012 Oct 26;151(3):630-44. doi: 10.1016/j.cell.2012.10.011.

引用本文的文献

1
Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review).癌症相关成纤维细胞的代谢重编程在肿瘤发生和进展中的作用(综述)
Int J Oncol. 2025 Nov;67(5). doi: 10.3892/ijo.2025.5796. Epub 2025 Aug 29.
2
TMEM65 functions as the mitochondrial Na/Ca exchanger.跨膜蛋白65(TMEM65)作为线粒体钠/钙交换体发挥作用。
Nat Cell Biol. 2025 Jul 21. doi: 10.1038/s41556-025-01721-x.
3
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance.解析缺氧、癌细胞干性和耐药性三者之间的关系。

本文引用的文献

1
MICU1 Serves as a Molecular Gatekeeper to Prevent In Vivo Mitochondrial Calcium Overload.MICU1作为分子守门人可防止体内线粒体钙超载。
Cell Rep. 2016 Aug 9;16(6):1561-1573. doi: 10.1016/j.celrep.2016.07.011. Epub 2016 Jul 28.
2
MDR1 mediated chemoresistance: BMI1 and TIP60 in action.多药耐药蛋白1介导的化疗耐药性:BMI1和TIP60发挥作用
Biochim Biophys Acta. 2016 Aug;1859(8):983-93. doi: 10.1016/j.bbagrm.2016.06.002. Epub 2016 Jun 22.
3
The Gene Expression Omnibus Database.基因表达综合数据库
J Hematol Oncol. 2025 Mar 18;18(1):32. doi: 10.1186/s13045-025-01684-4.
4
Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer.整合单细胞RNA测序和批量RNA测序以揭示乳酸化调控的代谢重编程与卵巢癌化疗耐药之间的关联及潜在分子机制。
Front Immunol. 2025 Feb 28;16:1513806. doi: 10.3389/fimmu.2025.1513806. eCollection 2025.
5
HRP2 regulating MICU1-mediated Ca overload to dictate chemoresistance of multiple myeloma.HRP2通过调节MICU1介导的钙超载来决定多发性骨髓瘤的化疗耐药性。
Neoplasia. 2025 Apr;62:101150. doi: 10.1016/j.neo.2025.101150. Epub 2025 Mar 8.
6
Targeting ion channels: innovative approaches to combat cancer drug resistance.靶向离子通道:对抗癌症耐药性的创新方法。
Theranostics. 2025 Jan 1;15(2):521-545. doi: 10.7150/thno.103384. eCollection 2025.
7
MICU2 up-regulation enhances tumor aggressiveness and metabolic reprogramming during colorectal cancer development.MICU2 上调增强结直肠癌发展过程中的肿瘤侵袭性和代谢重编程。
PLoS Biol. 2024 Oct 28;22(10):e3002854. doi: 10.1371/journal.pbio.3002854. eCollection 2024 Oct.
8
Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer.靶向线粒体:治疗铂耐药性卵巢癌的新方法。
J Transl Med. 2024 Oct 25;22(1):968. doi: 10.1186/s12967-024-05770-y.
9
Calcium signaling in mitochondrial intermembrane space.线粒体膜间隙中的钙信号传导。
Biochem Soc Trans. 2024 Oct 30;52(5):2215-2229. doi: 10.1042/BST20240319.
10
Orai1 and Orai3 act through distinct signalling axes to promote stemness and tumorigenicity of breast cancer stem cells.Orai1 和 Orai3 通过不同的信号通路发挥作用,促进乳腺癌干细胞的干性和致瘤性。
Stem Cell Res Ther. 2024 Aug 13;15(1):256. doi: 10.1186/s13287-024-03875-1.
Methods Mol Biol. 2016;1418:93-110. doi: 10.1007/978-1-4939-3578-9_5.
4
MICU1 regulation of mitochondrial Ca(2+) uptake dictates survival and tissue regeneration.MICU1对线粒体钙摄取的调节决定了生存和组织再生。
Nat Commun. 2016 Mar 9;7:10955. doi: 10.1038/ncomms10955.
5
Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.靶向EZH2通过调节头颈部鳞状细胞癌中线粒体依赖性细胞死亡途径来调控肿瘤生长和细胞凋亡。
Oncotarget. 2015 Oct 20;6(32):33720-32. doi: 10.18632/oncotarget.5606.
6
RPS3 regulates melanoma cell growth and apoptosis by targeting Cyto C/Ca2+/MICU1 dependent mitochondrial signaling.RPS3通过靶向细胞色素C/钙离子/线粒体钙摄取蛋白1依赖的线粒体信号传导来调节黑色素瘤细胞的生长和凋亡。
Oncotarget. 2015 Oct 6;6(30):29614-25. doi: 10.18632/oncotarget.4868.
7
Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication.糖酵解与线粒体氧化之间的代谢相互作用:逆瓦伯格效应及其治疗意义。
World J Biol Chem. 2015 Aug 26;6(3):148-61. doi: 10.4331/wjbc.v6.i3.148.
8
The Warburg effect: a balance of flux analysis.瓦伯格效应:通量分析的平衡
Metabolomics. 2015 Aug;11(4):787-796. doi: 10.1007/s11306-014-0760-9.
9
How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models.mtDNA 变化和线粒体功能障碍如何影响癌症和癌症治疗?挑战、机遇和模型。
Mutat Res Rev Mutat Res. 2015 Apr-Jun;764:16-30. doi: 10.1016/j.mrrev.2015.01.001. Epub 2015 Jan 20.
10
Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents.医学化学中丙酮酸脱氢酶激酶抑制剂的开发,特别强调作为抗癌药物。
Drug Discov Today. 2015 Sep;20(9):1112-9. doi: 10.1016/j.drudis.2015.03.012. Epub 2015 Apr 1.